Trial · NCT00927394
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Combination Therapy: Aliskiren + Valsartan | 575 | |
| Overall Study | STARTED | Monotherapy: Valsartan | 568 | |
| Overall Study | Cohort 1 (Randomized) | Combination Therapy: Aliskiren + Valsartan | 157 | |
| Overall Study | Cohort 1 (Randomized) | Monotherapy: Valsartan | 165 | |
| Overall Study | Cohort 2 (Randomized) | Combination Therapy: Aliskiren + Valsartan | 418 | |
| Overall Study | Cohort 2 (Randomized) | Monotherapy: Valsartan | 403 | |
| Overall Study | Combined Safety Set (Cohort 1 and 2) | Combination Therapy: Aliskiren + Valsartan | 574 | |
| Overall Study | Combined Safety Set (Cohort 1 and 2) | Monotherapy: Valsartan | 565 | |
| Overall Study | Cohort 1: Full Analysis Set 1 (FAS 1) | Combination Therapy: Aliskiren + Valsartan | 157 | |
| Overall Study | Cohort 1: Full Analysis Set 1 (FAS 1) | Monotherapy: Valsartan | 164 | |
| Overall Study | Cohort 2: Full Analysis Set 2 (FAS 2) | Combination Therapy: Aliskiren + Valsartan | 417 | |
| Overall Study | Cohort 2: Full Analysis Set 2 (FAS 2) | Monotherapy: Valsartan | 398 | |
| Overall Study | FAS 2 :Ambulatory Blood Pressure Monitor | Combination Therapy: Aliskiren + Valsartan | 342 | |
| Overall Study | FAS 2 :Ambulatory Blood Pressure Monitor | Monotherapy: Valsartan | 323 | |
| Overall Study | Combined Full Analysis Set (FAS 1+FAS 2) | Combination Therapy: Aliskiren + Valsartan | 574 | |
| Overall Study | Combined Full Analysis Set (FAS 1+FAS 2) | Monotherapy: Valsartan | 562 | |
| Overall Study | COMPLETED | Combination Therapy: Aliskiren + Valsartan | 498 | |
| Overall Study | COMPLETED | Monotherapy: Valsartan | 483 | |
| Overall Study | NOT COMPLETED | Combination Therapy: Aliskiren + Valsartan | 77 | |
| Overall Study | NOT COMPLETED | Monotherapy: Valsartan | 85 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00927394/flow